Lucas W. Buchanan - Jul 27, 2021 Form 4 Insider Report for Silk Road Medical Inc (SILK)

Role
COO/CFO
Signature
/s/Mhairi Jones, by power of attorney
Stock symbol
SILK
Transactions as of
Jul 27, 2021
Transactions value $
-$248,037
Form type
4
Date filed
7/29/2021, 07:41 PM
Previous filing
Jul 12, 2021
Next filing
Aug 31, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SILK Common Stock Options Exercise $4.8K +3K +1.61% $1.60* 189K Jul 27, 2021 Direct
transaction SILK Common Stock Options Exercise $71.9K +3.6K +1.9% $20.00 193K Jul 28, 2021 Direct F1
transaction SILK Common Stock Sale -$161K -3.6K -1.86% $44.91 189K Jul 28, 2021 Direct F1, F2
transaction SILK Common Stock Options Exercise $124K +4.02K +2.13% $30.93 193K Jul 28, 2021 Direct F1
transaction SILK Common Stock Sale -$181K -4.02K -2.08% $44.91 189K Jul 28, 2021 Direct F1, F2
transaction SILK Common Stock Sale -$107K -2.38K -1.26% $44.91 187K Jul 28, 2021 Direct F2, F3
holding SILK Common Stock 13.5K Jul 27, 2021 Buchanan Grandchildren's Irrevocable Trust F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SILK Option (right to buy) Options Exercise $0 -3K -2.17% $0.00 135K Jul 27, 2021 Common Stock 3K $1.60 Direct F5
transaction SILK Option (right to buy) Options Exercise $0 -3.6K -7.33% $0.00 45.4K Jul 28, 2021 Common Stock 3.6K $20.00 Direct F1, F6
transaction SILK Option (right to buy) Options Exercise $0 -4.02K -12.5% $0.00 28.2K Jul 28, 2021 Common Stock 4.02K $30.93 Direct F1, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on September 11, 2020.
F2 This transaction was executed in multiple trades at price ranging from $43.97 to $46.01. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 The sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on September 11, 2020.
F4 These shares are held directly by the Buchanan Grandchildren's Irrevocable Trust, for which the Reporting Person serves as a co-trustee.
F5 All of the shares subject to this option are fully vested and exercisable as of the date hereof.
F6 One forty-eighth of the shares subject to the option shall vest on May 3, 2019 and each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.
F7 One forty-eighth of the shares subject to the option shall vest on April 1, 2020 and each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.